跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lixiana - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lixiana
Approved
STANDARD
Lixiana
Daiichi Sankyo Europe GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fd89e72519ec36a8
Company
Daiichi Sankyo Europe GmbH
Type
Standard
Approval Details
Approval Id
fd89e72519ec36a8
Drug Approval Philippines Name
Lixiana
Product Name
Lixiana
Registration Number
DR-XY47212
Brand Name
Lixiana
Generic Name
Edoxaban (as tosilate)
Dosage Form
Film-Coated Tablet
Dosage Strength
30 mg
Manufacturer
Daiichi Sankyo Europe GmbH
Importer
A. Menarini Philippines, Inc.
Distributor
A. Menarini Philippines, Inc.
Company Detail Path
/organization/daiichi-sankyo-europe-gmbh
Issuance Date
29 March 2021
Expiry Date
29 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fd89e72519ec36a8
Type
Standard
Back to Philippines FDA Approvals